Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 11:04
Ernexa Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -575.9K% |
| September 30, 2024 | -5.46K% |
| June 30, 2024 | -11.76K% |
| March 31, 2024 | -14.14K% |
| December 31, 2023 | -36.19K% |
| September 30, 2023 | -10.96K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -25.02% |
| September 30, 2019 | -7.66% |
| June 30, 2019 | -1.72% |
| March 31, 2019 | -6.48% |
| December 31, 2018 | 0.88% |
| Date | Value |
|---|---|
| September 30, 2018 | 3.70% |
| June 30, 2018 | -2.19% |
| March 31, 2018 | -7.10% |
| December 31, 2017 | -12.07% |
| September 30, 2017 | -3.54% |
| June 30, 2017 | -2.96% |
| March 31, 2017 | -1.72% |
| December 31, 2016 | -7.68% |
| September 30, 2016 | -10.53% |
| June 30, 2016 | -15.72% |
| March 31, 2016 | -18.99% |
| December 31, 2015 | -15.18% |
| September 30, 2015 | -22.17% |
| June 30, 2015 | -42.39% |
| March 31, 2015 | -39.52% |
| December 31, 2014 | -25.45% |
| September 30, 2014 | -21.90% |
| June 30, 2014 | -19.61% |
| March 31, 2014 | -10.11% |
| December 31, 2013 | -5.34% |
| September 30, 2013 | -4.23% |
| June 30, 2013 | -1.79% |
| March 31, 2013 | -6.03% |
| December 31, 2012 | 10.60% |
| September 30, 2012 | 0.89% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cerenome, Inc. | -2.19K% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -299.3% |
| Return on Assets | -168.1% |
| Return on Invested Capital | -268.2% |
| Return on Net Operating Assets | -698.3% |